These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26981734)
1. Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients. Song SS; Goldenberg A; Ortiz A; Eimpunth S; Oganesyan G; Jiang SI JAMA Dermatol; 2016 Jun; 152(6):683-90. PubMed ID: 26981734 [TBL] [Abstract][Full Text] [Related]
2. A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery. Basu P; Goldenberg A; Cowan N; Eilers R; Hau J; Jiang SIB J Am Acad Dermatol; 2019 Jun; 80(6):1594-1601. PubMed ID: 30502411 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients. Cheng JY; Li FY; Ko CJ; Colegio OR JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858 [TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. Goldenberg A; Ortiz A; Kim SS; Jiang SB J Am Acad Dermatol; 2015 Jul; 73(1):120-6. PubMed ID: 25840729 [TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients. De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218 [TBL] [Abstract][Full Text] [Related]
6. Mohs versus surgical excision in nonmelanoma skin cancers: does location matter? Pereira CT; Kruger EA; Sayer G; Kim J; Hu J; Miller TA; Rudkin GH Ann Plast Surg; 2013 Apr; 70(4):432-4. PubMed ID: 23486132 [TBL] [Abstract][Full Text] [Related]
7. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708 [TBL] [Abstract][Full Text] [Related]
8. Overview on non-melanoma skin cancers in solid organ transplant recipients. Forchetti G; Suppa M; Del Marmol V G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224 [TBL] [Abstract][Full Text] [Related]
9. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654 [TBL] [Abstract][Full Text] [Related]
10. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773 [TBL] [Abstract][Full Text] [Related]
11. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601 [TBL] [Abstract][Full Text] [Related]
12. Periocular Skin Cancer in Solid Organ Transplant Recipients. Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170 [TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501 [TBL] [Abstract][Full Text] [Related]
14. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Batra RS; Kelley LC Arch Dermatol; 2002 Aug; 138(8):1043-51. PubMed ID: 12164742 [TBL] [Abstract][Full Text] [Related]
15. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017. Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669 [TBL] [Abstract][Full Text] [Related]
16. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619 [TBL] [Abstract][Full Text] [Related]
17. Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer. Scott FI; Mamtani R; Brensinger CM; Haynes K; Chiesa-Fuxench ZC; Zhang J; Chen L; Xie F; Yun H; Osterman MT; Beukelman T; Margolis DJ; Curtis JR; Lewis JD JAMA Dermatol; 2016 Feb; 152(2):164-72. PubMed ID: 26510126 [TBL] [Abstract][Full Text] [Related]
18. A Retrospective Analysis of Complication Rates in Mohs Micrographic Surgery Patients With Clinically Large Tumors and Tumors With Aggressive Subclinical Extension. Cowan N; Goldenberg A; Basu P; Eilers R; Hau J; I Brian Jiang S J Drugs Dermatol; 2018 May; 17(5):511-515. PubMed ID: 29742181 [TBL] [Abstract][Full Text] [Related]
19. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery. Schell AE; Russell MA; Park SS JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451 [TBL] [Abstract][Full Text] [Related]
20. The Risk of Internal Malignancy Following a Prior Diagnosis of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients. Gal N; Didkovsky E; Hodak E; Davidovici BB Isr Med Assoc J; 2022 Apr; 24(4):219-224. PubMed ID: 35415979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]